What You Should Know:
- Bicycle Health, a Boston, MA-based provider of virtual opioid addiction treatment secures $5M from Cobalt Ventures to further accelerate the expansion of its telehealth opioid use disorder (OUD) treatment.
- The additional capital extends Bicycle Health’s Series B venture capital financing, bringing the company’s total funding to date to $83M.
Evidence-based, online suboxone treatment for opioid addiction
Founded in 2017, Bicycle
Read More
venture capital
VC Firm General Catalyst Partners Lands First NHS Trust Partnership in UK
What You Should Know:
- Venture capital firm General Catalyst announced a partnership with Guy’s and St Thomas’ NHS Foundation Trust (GSTT), the largest hospital system in the UK with a diverse patient population and a longstanding commitment to innovation.
- As part of the partnership, General Catalyst and GSTT will work together to identify innovative digital solutions that benefit patients and providers by addressing problems such as hospital capacity constraints, long wait times and
Read More
Naveris Raises $51M for Early Detection of Viral-Driven Cancers
What You Should Know:
- Naveris, Inc., a commercial-stage life sciences company dedicated to improving patient care through earlier detection of viral-driven cancers, recently announced a $33.4M expansion of its Series A financing, bringing the total investment in Naveris to $51M.
- The financing was led by Gurnet Point Capital, joined by TechU Ventures and BrightEdge, the impact and venture capital arm of the American Cancer Society.
Using DNA Fragmentomics Technology to Detect
Read More
OurCrowd Launches $200M Global Health Equity Fund
OurCrowd Launches $200M Global Health Equity Fund
What You Should Know:
- Global venture firm OurCrowd launches the $200M Global Health Equity Fund (GHEF) in collaboration with the WHO Foundation.
- The fund team will be led by OurCrowd CEO, Jon Medved, and OurCrowd Managing Partner, Dr. Morris Laster, with the support of the WHO Foundation’s Chief Impact Investment Officer, Geetha Tharmaratnam. It will be managed by an OurCrowd team of clinical experts with decades of experience in
Read More
Redesign Health Raises $65M to Build Next-Gen Health Startups
What You Should Know:
- Redesign Health, a healthcare company that researches, builds and launches other healthcare companies raises $65M in Series C funding led by General Catalyst with participation from CVS Health Ventures, UPMC Enterprises (the innovation and venture capital arm of leading health system UPMC), Eden Global Partners, Euclidean Capital, Samsung Next, TriplePoint Capital, and founding investor Declaration Partners.
- In addition, General Catalyst,
Read More
Why You Should Use Digital Signage to Modernize Your Healthcare Communications
Patients seeking healthcare face a lot of hurdles – navigating the spaces where they receive care shouldn’t be one of them.
From preparing for the appointment while sitting in the waiting room to asking questions during the exam and taking care of administrative tasks as well as learning about products and services at the end of the visit, better provider-to-patient communication in care settings can improve how patients learn about their health and how they talk about it.
Digital
Read More
Naborforce Raises $9M to Connect Older Adults to On-Demand Support & Engagement
What You Should Know:
- Naborforce, a high-growth elder tech company that connects older adults to a network of trusted "Nabors" for on-demand support and social engagement, announced the closing of a $9 million Series A financing round led by Translink Capital.
- Translink Capital, a global venture capital firm headquartered in Silicon Valley, is joined by existing investors Claritas Capital The Artemis Fund, and TechStars. Naborforce will use the financing to further invest in its
Read More
Abridge Secures $12.5M to Power AI-Powered Medical Conversations
What You Should Know:
- Abridge, the leader in medical conversation artificial intelligence (AI), today announced an oversubscribed $12.5M Series A-1 led by Wittington Ventures.
- The round also had participation from all existing investors including Union Square Ventures, Bessemer Venture Partners, Pillar Venture Capital, and UPMC Enterprises, and new investors including Turing Award winner Yoshua Bengio, and Whistler Capital.
Automated Solutions to Combat Physician
Read More
Intel Invests $20M in Biofourmis’ Virtual Care Offerings
What You Should Know:
- Biofourmis, a Boston-based global leader in virtual care and digital medicine, today announced that Intel Capital, the strategic investment arm of chipmaker Intel Corporation, has joined its Series D financing in an extension that brings the total funding raised in the round to $320M.
- The initial Series D funding round was announced in April and was led by global growth equity firm General Atlantic with participation by CVS Health (NYSE:CVS), Trevor
Read More
VC General Catalyst Closes $675M Health Assurance Fund II
What You Should Know:
- Early-stage venture capital firm General Catalyst closes $670 million Health Assurance Fund II.
- The new fund comes on the heels of the Health Assurance Fund I closed in April of 2021 at $600M. To date, General Catalyst has invested $1.7B in companies aligned with the health assurance thesis.
Health Assurance Fund II Investment Thesis
This new fund will allow us to continue to accelerate General Catalyst’s work on building a value-oriented system and focus
Read More
